CereVasc
Auburndale
About CereVasc
CereVasc is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. Current treatment of these patients requires an invasive, neurosurgical procedure with a documented rate of success well below the success rate for other neurosurgical interventions. The eShunt System has the potential to significantly improve patient outcomes and substantially decrease the overall cost of surgical treatment of this life-threatening condition.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $114.0M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2024)
- Website: cerevasc.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/cerevasc-8071 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.